LEARNING OBJECTIVES:
Review the etiologies of somnolescense; ICSD- 3 criteria for CDH/central disorders of hypersomnia; AASM workup for EDS/excessive daytime sleepiness; DDx; AASM clinical practice guidelines (JCSM 09/01/2021 N. Watson); Features of NT1 vs NT2 vs IH; Neurohistopathology; Hypocretin/orexinergia; Testings – especially the IHSS or idiopathic hypersomnia severity scale; QOL and functional impact of EDS; Classic + Novel treatments – GHB and LXB and SXB; Date Rape Prohibition Act of 2000; Impact of COVID-19 on IH (JCSM); debate(s).
Ballroom California Sleep Society leigh@xenicus.comLEARNING OBJECTIVES:
Review the etiologies of somnolescense; ICSD- 3 criteria for CDH/central disorders of hypersomnia; AASM workup for EDS/excessive daytime sleepiness; DDx; AASM clinical practice guidelines (JCSM 09/01/2021 N. Watson); Features of NT1 vs NT2 vs IH; Neurohistopathology; Hypocretin/orexinergia; Testings – especially the IHSS or idiopathic hypersomnia severity scale; QOL and functional impact of EDS; Classic + Novel treatments – GHB and LXB and SXB; Date Rape Prohibition Act of 2000; Impact of COVID-19 on IH (JCSM); debate(s).
